日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Inhibition of BET Bromodomain Proteins with GS-5829 and GS-626510 in Uterine Serous Carcinoma, a Biologically Aggressive Variant of Endometrial Cancer

使用 GS-5829 和 GS-626510 抑制子宫浆液性癌(一种生物侵袭性子宫内膜癌变体)中的 BET 溴结构域蛋白

Elena Bonazzoli, Federica Predolini, Emiliano Cocco, Stefania Bellone, Gary Altwerger, Gulden Menderes, Luca Zammataro, Anna Bianchi, Francesca Pettinella, Francesco Riccio, Chanhee Han, Ghanshyam Yadav, Salvatore Lopez, Aranzazu Manzano, Paola Manara, Natalia Buza, Pei Hui, Serena Wong, Babak Litko

Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro

子宫肿瘤中的聚合酶ε(POLE)超突变与 T 淋巴细胞浸润和体外对铂类化疗的耐药性增加相关

Stefania Bellone, Eliana Bignotti, Silvia Lonardi, Francesca Ferrari, Floriana Centritto, Alice Masserdotti, Francesca Pettinella, Jonathan Black, Gulden Menderes, Gary Altwerger, Pei Hui, Salvatore Lopez, Christopher de Haydu, Elena Bonazzoli, Federica Predolini, Luca Zammataro, Emiliano Cocco, Fed

Dual CCNE1/PIK3CA targeting is synergistic in CCNE1-amplified/PIK3CA-mutated uterine serous carcinomas in vitro and in vivo

CCNE1/PIK3CA 双靶向作用在体外和体内 CCNE1 扩增/PIK3CA 突变的子宫浆液性癌中具有协同作用

Emiliano Cocco, Salvatore Lopez, Jonathan Black, Stefania Bellone, Elena Bonazzoli, Federica Predolini, Francesca Ferrari, Carlton L Schwab, Gulden Menderes, Luca Zammataro, Natalia Buza, Pei Hui, Serena Wong, Siming Zhao, Yalai Bai, David L Rimm, Elena Ratner, Babak Litkouhi, Dan-Arin Silasi, Masou

Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition

子宫和卵巢癌肉瘤的突变图谱表明组蛋白基因参与了上皮-间质转化

Siming Zhao, Stefania Bellone, Salvatore Lopez, Durga Thakral, Carlton Schwab, Diana P English, Jonathan Black, Emiliano Cocco, Jungmin Choi, Luca Zammataro, Federica Predolini, Elena Bonazzoli, Mark Bi, Natalia Buza, Pei Hui, Serena Wong, Maysa Abu-Khalaf, Antonella Ravaggi, Eliana Bignotti, Elisab

PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas

PIK3CA 致癌突变是 HER2/neu 过度表达的子宫浆液性癌对曲妥珠单抗产生耐药性的主要机制

Jonathan D Black, Salvatore Lopez, Emiliano Cocco, Stefania Bellone, Gary Altwerger, Carlton L Schwab, Diana P English, Elena Bonazzoli, Federica Predolini, Francesca Ferrari, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Peter E Schwartz, Alessandro D Santin

Dual HER2/PIK3CA Targeting Overcomes Single-Agent Acquired Resistance in HER2-Amplified Uterine Serous Carcinoma Cell Lines In Vitro and In Vivo

HER2/PIK3CA 双靶向治疗在体内和体外克服了 HER2 扩增子宫浆液性癌细胞系中单药获得性耐药性

Salvatore Lopez, Emiliano Cocco, Jonathan Black, Stefania Bellone, Elena Bonazzoli, Federica Predolini, Francesca Ferrari, Carlton L Schwab, Diana P English, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Peter E Schwartz, Corrado Terranova, Roberto Angioli, Alessandro D Santin

Polymerase ε (POLE) ultra-mutated tumors induce robust tumor-specific CD4+ T cell responses in endometrial cancer patients

聚合酶 ε (POLE) 超突变肿瘤在子宫内膜癌患者中诱导强烈的肿瘤特异性 CD4+ T 细胞反应

Stefania Bellone, Floriana Centritto, Jonathan Black, Carlton Schwab, Diana English, Emiliano Cocco, Salvatore Lopez, Elena Bonazzoli, Federica Predolini, Francesca Ferrari, Dan-Arin Silasi, Elena Ratner, Masoud Azodi, Peter E Schwartz, Alessandro D Santin

Dacomitinib (PF-00299804), a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor, demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro

达克替尼 (PF-00299804) 是一种第二代不可逆泛 erbB 受体酪氨酸激酶抑制剂,体外对 HER2 扩增的子宫浆液性子宫内膜癌表现出显著的活性

Liancheng Zhu, Salvatore Lopez, Stefania Bellone, Jonathan Black, Emiliano Cocco, Tiffany Zigras, Federica Predolini, Elena Bonazzoli, Beatrice Bussi, Zachary Stuhmer, Carlton L Schwab, Diana P English, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Peter E Schwartz, Thomas J Rutherford, Alessandro D